Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis

被引:17
作者
Anderson, Tarah M. Regan [1 ,2 ,3 ]
Ma, Shihong [4 ]
Kerkvliet, Carlos Perez [1 ,2 ,3 ]
Peng, Yan [4 ]
Helle, Taylor M. [1 ,2 ,3 ]
Krutilina, Raisa I. [5 ,8 ]
Raj, Ganesh V. [4 ]
Cidlowski, John A. [5 ]
Ostrander, Julie H. [1 ,2 ,3 ]
Schwertfeger, Kathryn L. [6 ,7 ]
Seagroves, Tiffany N. [8 ]
Lange, Carol A. [1 ,2 ,3 ]
机构
[1] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Pharmacol, Div Hematol Oncol & Transplantat, 3-249 Millard Hall, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Masonic Canc Ctr, MMC 806 Mayo 8806A,420 Delaware St SE, Minneapolis, MN 55455 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[5] NIEHS, Lab Signal Transduct, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA
[6] Univ Minnesota, Dept Lab Med & Pathol, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[7] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA
[8] Univ Tennessee, Ctr Hlth Sci, Dept Pathol, Memphis, TN 38163 USA
关键词
TUMOR KINASE BRK/PTK6; BREAST-CANCER; GLUCOCORTICOID-RECEPTOR; ANOIKIS RESISTANCE; ESTROGEN-RECEPTOR; ACTIVATION; DEGRADATION; INHIBITION; EXPRESSION; OVEREXPRESSION;
D O I
10.1158/1541-7786.MCR-18-0410
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The metastatic cascade is a complex process that requires cancer cells to survive despite conditions of high physiologic stress. Previously, cooperation between the glucocorticoid receptor (GR) and hypoxia-inducible factors (HIF) was reported as a point of convergence for host and cellular stress signaling. These studies indicated p38 MAPK-dependent phosphorylation of GR on Ser134 and subsequent p-GR/HIF-dependent induction of breast tumor kinase (PTK6/Brk), as a mediator of aggressive cancer phenotypes. Herein, p-Ser134 GR was quantified in human primary breast tumors (n = 281) and the levels of p-GR were increased in triplenegative breast cancer (TNBC) relative to luminal breast cancer. Brk was robustly induced following exposure of TNBC model systems to chemotherapeutic agents (Taxol or 5-fluorouracil) and growth in suspension [ultra-low attachment (ULA)]. Notably, both Taxol and ULA resulted in upregulation of the Aryl hydrocarbon receptor (AhR), a known mediator of cancer prosurvival phenotypes. Mecha-nistically, AhR and GR copurified and following chemotherapy and ULA, these factors assembled at the Brk promoter and induced Brk expression in an HIF-dependent manner. Furthermore, Brk expression was upregulated in Taxol-resistant breast cancer (MCF-7) models. Ultimately, Brk was critical for TNBC cell proliferation and survival during Taxol treatment and in the context of ULA as well as for basal cancer cell migration, acquired biological phenotypes that enable cancer cells to successfully complete the metastatic cascade. These studies nominate AhR as a p-GR binding partner and reveal ways to target epigenetic events such as adaptive and stress-induced acquisition of cancer skill sets required for metastatic cancer spread. Implication: Breast cancer cells enlist intracellular stress response pathways that evade chemotherapy by increasing cancer cell survival and promoting migratory phenotypes. (C) 2018 AACR.
引用
收藏
页码:1761 / 1772
页数:12
相关论文
共 50 条
  • [1] Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer
    Agyeman, Abena S.
    Jun, Wesley J.
    Proia, David A.
    Kim, Caroline R.
    Skor, Maxwell N.
    Kocherginsky, Masha
    Conzen, Suzanne D.
    [J]. HORMONES & CANCER, 2016, 7 (02): : 114 - 126
  • [2] Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition
    Ai, Midan
    Liang, Ke
    Lu, Yang
    Qiu, Songbo
    Fan, Zhen
    [J]. CANCER BIOLOGY & THERAPY, 2013, 14 (03) : 237 - 245
  • [3] Allred DC, 1998, MODERN PATHOL, V11, P155
  • [4] Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer
    Anderson, Tarah M. Regan
    Ma, Shi Hong
    Raj, Ganesh V.
    Cidlowski, John A.
    Helle, Taylor M.
    Knutson, Todd P.
    Krutilina, Raisa I.
    Seagroves, Tiffany N.
    Lange, Carol A.
    [J]. CANCER RESEARCH, 2016, 76 (06) : 1653 - 1663
  • [5] Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression
    Anderson, Tarah M. Regan
    Peacock, Danielle L.
    Daniel, Andrea R.
    Hubbard, Gregory K.
    Lofgren, Kristopher A.
    Girard, Brian J.
    Schoerg, Alexandra
    Hoogewijs, David
    Wenger, Roland H.
    Seagroves, Tiffany N.
    Lange, Carol A.
    [J]. CANCER RESEARCH, 2013, 73 (18) : 5810 - 5820
  • [6] Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor
    Brooks, J.
    Eltom, S. E.
    [J]. CURRENT CANCER DRUG TARGETS, 2011, 11 (05) : 654 - 669
  • [7] CLONING OF THE AH-RECEPTOR CDNA REVEALS A DISTINCTIVE LIGAND-ACTIVATED TRANSCRIPTION FACTOR
    BURBACH, KM
    POLAND, A
    BRADFIELD, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (17) : 8185 - 8189
  • [8] Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer
    Buxant, Frederic
    Engohan-Aloghe, Corine
    Noel, Jean-Christophe
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (03): : 254 - 257
  • [9] Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells
    Castro, Nancy E.
    Lange, Carol A.
    [J]. BREAST CANCER RESEARCH, 2010, 12 (04)
  • [10] EMT, cell plasticity and metastasis
    Chaffer, Christine L.
    San Juan, Beatriz P.
    Lim, Elgene
    Weinberg, Robert A.
    [J]. CANCER AND METASTASIS REVIEWS, 2016, 35 (04) : 645 - 654